[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100542551":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":38,"locations":49,"responsibleParty":69,"collaborators":26,"id":71,"slug":72,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":77,"eligibilityCriteria":78,"healthyVolunteers":73,"sex":79,"minAge":80,"maxAge":81,"enrollmentInfo":82,"targetDuration":26,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":26,"overallStatus":52,"whyStopped":26,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Xuanwu Hospital, Beijing","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"tDCS treatment group","EXPERIMENTAL","In the real tDCS stimulation group, direct cathodal current at 2 mA was delivered by a tDCS device over the seizure onset zone. Anode was on the contralateral forehead. Treatment was for 20 min, repeated twice in a day, then again over the next few days. The maximum number of stimuli required to terminate the status epilepticus should not exceed 10.",[13],"Device: tDCS stimulation",{"label":15,"type":16,"description":17,"interventionNames":18},"TDCS sham-stimulation group","SHAM_COMPARATOR","The duration and frequency of tDCS treatments in the sham-stimulation group are the same as those in the treatment group, but the tDCS device is not active during the 20 minutes of sham-stimulation.",[19],"Device: TDCS sham-stimulation",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","tDCS stimulation","In the real-stimulation group, Treatment was for 20 min, repeated twice in a day, then again over the next few days. The maximum number of stimuli required to terminate the status epilepticus should not exceed 10. In the sham-stimulation group, The duration and frequency of tDCS are the same as those in the treatment group, but the tDCS device is not active during the 20 minutes of sham-stimulation",[9],null,{"type":22,"name":28,"description":28,"armGroupLabels":29,"otherNames":26},"TDCS sham-stimulation",[15],[31,34],{"name":32,"affiliation":5,"role":33},"Weibi Chen, Dr","STUDY_DIRECTOR",{"name":35,"affiliation":36,"role":37},"Jiaqing Yan, Dr","College of Electrical and Control Engineering, North China University of Technology","PRINCIPAL_INVESTIGATOR",[39,45],{"name":40,"role":41,"phone":42,"phoneExt":43,"email":44},"research centre of Xuanwu hospital Capital Medical University","CONTACT","+8601083198899","8270","liugangqingyi@sina.com",{"name":46,"role":41,"phone":47,"phoneExt":26,"email":48},"Jiaqing Tian, Dr","+8615311415116","smile21tian@163.com",[50],{"facility":51,"status":52,"city":53,"state":54,"zip":55,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":64},"Xuanwu Hospital, Capital Medical University","RECRUITING","Beijing","Beijing Municipality","100053","China","CN",{"type":59,"coordinates":60},"Point",[61,62],116.39723,39.9075,{"lat":62,"lon":61},[65],{"name":66,"role":41,"phone":67,"phoneExt":26,"email":68},"Weibi Chen","+8615010255903","chenweibi@126.com",{"type":37,"investigatorFullName":66,"investigatorTitle":70,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"associate professor","100542551","application-of-tdcs-stimulation-in-controlling-refractory-status-epilepticus-100542551",false,"NCT06344338","Application of tDCS Stimulation in Controlling Refractory Status Epilepticus","Application of Targeting Transcranial Direct Current Stimulation (tDCS) Stimulation in the Treatment of Refractory Status Epilepticus","tDCS","Inclusion Criteria:\n\n* Age between 14 and 80 year-old with Gender unlimited,\n* Suitable for EEG monitoring;\n* Clinical diagnosis of Refractory status epilepticus (status epilepticus that cannot be controlled by two types of antiepileptic drugs and at least one anesthetic);\n* Informed consent to participate in this study was obtained from the participants or their surrogates\n\nExclusion Criteria:\n\n* Unstable vital signs (systolic blood pressure\\\u003C90mmHg, heart rate\\\u003C60 beats\u002Fmin, pulse oxygen saturation\\\u003C90%);\n* Having severe skull injury\u002Fdefect or medical equipment implanted in the head;\n* Pregnancy;\n* With any implantable electronic instrument (including pacemakers, vagus nerve stimulators) or metal implanted devices.","ALL","14 Years","80 Years",{"count":83,"type":84},32,"ESTIMATED","INTERVENTIONAL",[87],"NA","The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus",[90],"Refractory Status Epilepticus","2024-07-30",{"date":93,"type":94},"2024-07-31","ACTUAL",{"date":96,"type":94},"2024-04-01",{"date":98,"type":84},"2025-03-31",{"name":5,"class":6},1]